LEADER 01829nam  2200397   450 
001 9910794493203321
005 20230629234622.0
010   $a0-89042-474-8
035   $a(CKB)4100000011516338
035   $a(MiAaPQ)EBC6373791
035   $a(EXLCZ)994100000011516338
100   $a20201206d2021      uy             0
101 0 $aeng
135   $aurcnu||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 14$aThe American Psychiatric Association practice guideline for the treatment of patients with schizophrenia /$fAmerican Psychiatric Association
205   $aThird edition.
210  1$aWashington, District of Columbia :$cAmerican Psychiatric Association,$d[2021]
210  4$dİ2021
215   $a1 online resource (xi, 297 pages)
311   $a0-89042-484-5 
311   $a0-89042-469-1 
330   $a"The goal of this practice guideline is to improve the quality of care and treatment outcomes for patients with schizophrenia. The guideline aims to help clinicians optimize care for their patients by providing evidence-based statements that are intended to enhance knowledge and increase the appropriate use of evidence-based pharmacological and nonpharmacological treatments for schizophrenia. In addition, it includes statements related to assessment and treatment planning, which are an integral part of patient-centered care"--$cProvided by publisher.
606   $aSchizophrenia$xTreatment
608   $aPractice Guideline
615  0$aSchizophrenia$xTreatment.
676   $a616.898
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910794493203321
996   $aThe American Psychiatric Association practice guideline for the treatment of patients with schizophrenia$93820195
997   $aUNINA